The FDAs approval of Lillys molecule is based on the companys Phase 3 clinical trials, which showed that participants lost an average of 12.4% of their body weight after 72 weeks on the highest dose, compared with just 0.9% for those on a placebo
Let's use 2mL of bacteriostatic water as a common example
The hype is driven by marketing, not medicine
Under ischemic and high-stress conditions, GLP-1R activation increases myocardial glucose uptake and glycolytic flux while inhibiting caspase-3mediated cardiomyocyte apoptosis
This was first demonstrated by finding that chemical inhibition of the neutrophil oxidative burst exhibited PPP and G6PD dependence ( ex vivo ( Figure 1B-1 ): phagocytosis, release of neutrophil extracellular traps (NETs), and degranulation accompanied by rapid production of large amounts of extracellular ROS
Weight gain is a common consequence of adjuvant treatment for breast cancer ( In this report, both the patients impairment score and limb volume correlated with both weight gain and weight loss